Clinical Trial Update: Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating antepartum betamethasone to prevent respiratory distress in infants born by elective cesarean section was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• betamethasone (betamethasone)

Snippet

Sponsor: Emory University | Conditions: Respiratory Distress Syndrome, Newborn | Phase 2, Phase 3 | Status: TERMINATED